ArticleInfluenza and other respiratory viruses2024

Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.

Clara Mazagatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.